BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29077903)

  • 1. Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New Millennium.
    Raue F; Dralle H; Machens A; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2018 Jan; 103(1):235-243. PubMed ID: 29077903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to recognize multiple endocrine neoplasia 2B: more common than we think?
    Wray CJ; Rich TA; Waguespack SG; Lee JE; Perrier ND; Evans DB
    Ann Surg Oncol; 2008 Jan; 15(1):293-301. PubMed ID: 17963006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center.
    Raue F; Bruckner T; Frank-Raue K
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
    Brauckhoff M; Machens A; Lorenz K; Bjøro T; Varhaug JE; Dralle H
    Ann Surg; 2014 Apr; 259(4):800-6. PubMed ID: 23979292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians.
    Camacho CP; Hoff AO; Lindsey SC; Signorini PS; Valente FO; Oliveira MN; Kunii IS; Biscolla RP; Cerutti JM; Maciel RM
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1393-8. PubMed ID: 19169500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
    Castinetti F; Waguespack SG; Machens A; Uchino S; Hasse-Lazar K; Sanso G; Else T; Dvorakova S; Qi XP; Elisei R; Maia AL; Glod J; Lourenço DM; Valdes N; Mathiesen J; Wohllk N; Bandgar TR; Drui D; Korbonits M; Druce MR; Brain C; Kurzawinski T; Patocs A; Bugalho MJ; Lacroix A; Caron P; Fainstein-Day P; Borson Chazot F; Klein M; Links TP; Letizia C; Fugazzola L; Chabre O; Canu L; Cohen R; Tabarin A; Spehar Uroic A; Maiter D; Laboureau S; Mian C; Peczkowska M; Sebag F; Brue T; Mirebeau-Prunier D; Leclerc L; Bausch B; Berdelou A; Sukurai A; Vlcek P; Krajewska J; Barontini M; Vaz Ferreira Vargas C; Valerio L; Ceolin L; Akshintala S; Hoff A; Godballe C; Jarzab B; Jimenez C; Eng C; Imai T; Schlumberger M; Grubbs E; Dralle H; Neumann HP; Baudin E
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):213-220. PubMed ID: 30660595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].
    Frank-Raue K; Heimbach C; Rondot S; Usadel KH; Meng W; Varma C; Fuchs-Hammoser R; Höppner W; Schulze E; Raue F
    Dtsch Med Wochenschr; 2003 Sep; 128(39):1998-2002. PubMed ID: 14508694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
    Lodish MB; Stratakis CA
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
    Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
    Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.
    Nakao KT; Usui T; Ikeda M; Mori Y; Yamamoto T; Kawashima ST; Nanba K; Yuno A; Tamanaha T; Tagami T; Naruse M; Asato R; Shimatsu A
    Head Neck; 2013 Dec; 35(12):E363-8. PubMed ID: 23468374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.
    Jasim S; Ying AK; Waguespack SG; Rich TA; Grubbs EG; Jimenez C; Hu MI; Cote G; Habra MA
    Thyroid; 2011 Feb; 21(2):189-92. PubMed ID: 21186952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the genotype-phenotype correlation in children with medullary thyroid carcinoma: A report from the GPOH-MET registry.
    Kuhlen M; Frühwald MC; Dunstheimer DPA; Vorwerk P; Redlich A
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28171. PubMed ID: 31925938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.
    Leboulleux S; Travagli JP; Caillou B; Laplanche A; Bidart JM; Schlumberger M; Baudin E
    Cancer; 2002 Jan; 94(1):44-50. PubMed ID: 11815959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Reality of Multiple Endocrine Neoplasia Type 2B Diagnosis: Awareness of Unique Physical Appearance Is Important.
    Nagaoka R; Sugitani I; Sanada M; Jikuzono T; Okamura R; Igarashi T; Akasu H; Shimizu K
    J Nippon Med Sch; 2018; 85(3):178-182. PubMed ID: 30135345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2B].
    Mathiesen JS; Døssing H; Bender L; Godballe C
    Ugeskr Laeger; 2014 Jan; 176(5A):. PubMed ID: 27498810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.